Premature infants (delivery before 37 wk of gestation) admitted to the NICU at the University of Iowa Children's Hospital between 2000 and 2009 were recruited to examine preterm birth (PTB) and ...
Hemophilia A and B are similar conditions that affect the blood’s ability to clot. They typically occur due to gene variations that affect different blood clotting factors. Hemophilia is a group of ...
Research led by Christian Medical College in Vellore, India, has demonstrated the successful use of lentiviral vectors to deliver gene therapy for patients with severe hemophilia A. The study presents ...
Hemophilia is a bleeding disorder that can affect the blood’s ability to clot properly. In most cases, people inherit the gene variations for hemophilia in an X-linked recessive inheritance pattern.
A Takeda Pharmaceutical drug is now the first FDA-approved therapy for a rare, inherited enzyme deficiency that leads to blood clotting problems and a cascade of complications, some of them ...
Screening children for certain clotting proteins may help clinicians in resource-poor settings identify serious complications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results